Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood

Stem Cell Research

Volumn 11, Issue 1, 2013, Pages 625-633

  Brunet de la Grange, Philippe ^a,b   Vlaski, Marija ^a,b   Duchez, Pascale ^a,b   Chevaleyre, Jean ^a,b   Lapostolle, Veronique ^b   Boiron, Jean Michel ^a,b   Praloran, Vincent ^b   Ivanovic, Zoran ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b CNRS Bordeaux Segalen University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; THY 1 ANTIGEN;

ARTICLE; CELL CULTURE; CELL EXPANSION; CELL SUBPOPULATION; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; EX VIVO STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LONG TERM CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT COURSE THERAPY; SIDE POPULATION CELL; STEADY STATE;

ANIMALS; CELL SEPARATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; SIDE-POPULATION CELLS;

EID: 84877358426     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.04.003     Document Type: Article

References (46)

1. Asakura A., Rudnicki M.A. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 2002, 30:1339-1345.
2. Barr R.D., Whang-Peng J., Perry S. Hemopoietic stem cells in human peripheral blood. Science 1975, 190:284-285.
3. Bender J.G., Unverzagt K.L., Walker D.E., Lee W., Van Epps D.E., Smith D.H., Stewart C.C., To L.B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991, 77:2591-2596.
4. Boiron J.M., Dazey B., Cailliot C., Launay B., Attal M., Mazurier F., McNiece I.K., Ivanovic Z., Caraux J., Marit G., Reiffers J. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 2006, 46:1934-1942.
5. Brecher G., Cronkite E.P. Post-irradiation parabiosis and survival in rats. Proc. Soc. Exp. Biol. Med. 1951, 77:292-294.
6. Cavins J.A., Scheer S.C., Thomas E.D. The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at -80°C. Blood 1964, 23:38-43.
7. Challen G.A., Little M.H. A side order of stem cells: the SP phenotype. Stem Cells 2006, 24:3-12.
8. Chervenick P.A., Boggs D.R. In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals. Blood 1971, 37:131-135.
9. Danet G.H., Lee H.W., Luongo J.L., Simon M.C., Bonnet D.A. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp. Hematol. 2001, 29:1465-1473.
10. Ema H. In vivo and in vitro essays for HSCs. Hematopoietic Stem Cells Biology 2010, 6-110. Humana Press, Springer, New York. M. Kondo (Ed.).
11. Goodell M.A. Multipotential stem cells and 'side population' cells. Cytotherapy 2002, 4:507-518.
12. Goodman J.W., Hodgson G.S. Evidence for stem cells in the peripheral blood of mice. Blood 1962, 19:702-714.
13. Hirayama F., Yamaguchi M., Yano M., Yasui K., Horie Y., Matsumoto K., Nagao N., Ikebuchi K., Azuma H., Ikeda H., Tani Y. Spontaneous and rapid reexpression of functional CXCR4 by human steady-state peripheral blood CD34+ cells. Int. J. Hematol. 2003, 78:48-55.
14. Ivanovic Z., Milenkovic P. Pluripotent haemopoietic progenitor cells (CFU-Sd8) in peripheral blood of hereditarily anaemic Belgrade (b/b) rats. Lab. Anim. 1999, 33:77-82.
15. Ivanovic Z., Petakov M., Jovcic G., Biljanovic-Paunovic L., Balint B., Milenkovic P. Pluripotent and committed haemopoietic progenitor cells in rat peripheral blood. Comp. Haematol. Int. 1997, 7:1-6.
16. Ivanovic Z., Hermitte F., Brunet de la Grange P., Dazey B., Belloc F., Lacombe F., Vezon G., Praloran V. Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells 2004, 22:716-724.
17. + progrenitors potentially usable in cell therapy. Transfusion 2006, 46:118-125.
18. Ivanovic Z., Duchez P., Dazey B., Hermitte F., Lamrissi-Garcia I., Mazurier F., Praloran V., Reiffers J., Vezon G., Boiron J.M. A clinical-scale expansion of mobilized CD34+ haematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 2006, 46:126-131.
19. Ivanovic Z., Duchez P., Chevaleyre J., Vlaski M., Lafarge X., Dazey B., Robert-Richard E., Mazurier F., Boiron J.M. Clinical-scale cultures of cord blood CD34+ cells to amplify committed progenitors and maintain stem cell activity. Cell Transplant. 2011, 20:1453-1463.
20. Johnnidis J.B., Camargo F.D. Isolation and functional characterization of side population stem cells. Methods Mol. Biol. 2008, 430:183-193.
21. Josefsen D., Forfang L., Dyrhaug M., Blystad A.K., Stokke T., Smeland E.B., Kvalheim G. Side population cells in highly enriched CD34-poitive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy. Eur. J. Haematol. 2011, 87:494-502.
22. Kessinger A., Smith D.M., Strandjourd S.E., Landmark J.D., Dooley D.C., Law P., Coccia P.F., Warkentin P.I., Weisenburger D.D., Armitage J.O. Allogenic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukaemia. Bone Marrow Transplant. 1989, 4:643-646.
23. Kim M., Turnquist H., Jackson J., Sgagias M., Yan Y., Gong M., Dean M., Sharp J.G., Cowan K. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin. Cancer Res. 2002, 8:22-28.
24. Korbling M., Fliedner T.M., Calvo W., Ross W.M., Nothdurft W., Steinbach I. Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): long-term allogenic engraftment without GVH-reaction. Exp. Hematol. 1979, 7:277-288.
25. Korbling M., Dorken B., Ho A.D., Pezzuto A., Hunstein W., Fliedner T.M. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986, 67:529-532.
26. Lataillade J.J., Clay D., David C., Boutin L., Guerton B., Drouet M., Hérodin F., Le Bousse-Kerdilès M.C. Phenotypic and functional characteristics of CD34+ cells are related to their anatomical environment: is their versatility a prerequisite for their bio-availability?. J. Leukoc. Biol. 2005, 77:634-643.
27. Lin K.K., Goodell M.A. Purification of hematopoietic stem cells using the side population. Methods Enzymol. 2006, 420:255-264.
28. Mathew G., Timm E.A., Sotomayor P., Godoy A., Montecinos V.P., Smith G.J., Huss W.J. ABCG2-mediated Dye Cycle Violet efflux defined side population in benign and malignant prostate. Cell Cycle 2009, 8:1053-1061.
29. McCredie K.B., Hersh E.M., Freireich E.J. Cells capable of colony formation in the peripheral blood of man. Science 1971, 171:293-294.
30. Milpied N., Dazey B., Ivanovic Z., Duchez P., Vigouroux S., Tabrizi R., Pigneux A., Dilhuydy M.S., Bouabdallah K., Leguay T., Sauvezie M., Boiron J.M. Rapid and sustained engraftment of a single allogeneic ex-vivo expanded cord blood unit (CBU) after reduced intensity conditioning (RIC) in adults: preliminary results of a prospective trial. ASH Congress, San Diego, USA. Blood 2011, 118(21):226. Abstract 226.
31. Peytour Y., Guitart A., Villacreces A., Chevaleyre J., Lacombe F., Ivanovic Z., Praloran V. Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters. Transfusion 2010, 50:2152-2157.
32. Pierre-Louis O., Clay D., Brunet de la Grange P., Blazsek I., Desterke C., Guerton B., Blondeau C., Malfuson J.V., Prat M., Bennaceur-Griscelli A., Lataillade J.J., Le Bousse-Kerdilès M.C. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD34-stem/progenitor cell compartment. Stem Cells 2009, 27:2552-2562.
33. Reiffers J., Bernard P., David B., Vezon G., Sarrat A., Marit G., Moulinier J., Broustet A. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukaemia. Exp. Hematol. 1986, 14:312-315.
34. Reiffers J., Cailliot C., Dazey B., Attal M., Caraux J., Boiron J.M. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999, 354:1092-1093.
35. Richman C.M., Weiner R.S., Yankee R.A. Increase in circulating stem cells following chemotherapy in man. Blood 1976, 47:1031-1039.
36. Robert-Richard E., Ged C., Ortet J., Santarelli X., Lamrissi-Garcia I., de Verneuil H., Mazurier F. Human cell engraftment after busulfan or irradiation conditioning of NOD/SCID mice. Haematologica 2006, 91:1384-1387.
37. She J.J., Zhang P.G., Wang Z.M., Gan W.M., Che X.M. Identification of side population cells from bladder cancer cells by Dye Cycle Violet staining. Cancer Biol. Ther. 2008, 7:1663-1668.
38. Siena S., Bregni M., Ravagnani F., Brando B., Tarella C., Bonadonna G., Gianni A.M. Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF). Haematologica 1990, 75(Suppl. 1):6-10.
39. Storb R., Epstein R.B., Thomas E.D. Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. Blood 1968, 50:537-542.
40. Storb R., Graham T.C., Epstein R.B., Sale G.E., Thomas E.D. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977, 50:537-542.
41. Sutherland D.R., Anderson L., Keeney M., Nayar R., Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J. Hematother. 1996, 5:213-226.
42. Tanaka T., Tsudo M., Karasuyama H., Kitamura F., Kono T., Hatakeyama M., Taniguchi T., Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 1991, 147:2222-2228.
43. Telford W.G., Bradford J., Godfrey W., Robey R.W., Bates S.E. Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells 2007, 25:1029-1036.
44. Uchida N., Fujisaki T., Eaves A.C., Eaves C.J. Transplantable hematopoietic stem cells in human fetal liver have a CD34+ side population (SP) phenotype. J. Clin. Invest. 2001, 1058:1071-1077.
45. Udomsakdi C., Lansdorp P.M., Hoggs D.E., Reid D.C., Eaves A.C., Eaves C.J. Characteristic of primitive hematopoietic cells in normal human peripheral blood. Blood 1992, 80:2513-2521.
46. Utter G.H., Lee T.H., Rivers R.M., Montalvo L., Wen L., Chafets D.M., Reed W.F., Busch M.P. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008, 48:1609-1615.